Pyrosolo-quinazoline derivatives, their method of production and their use as kinase inhibitors
Iceland Patent
Stats

Importance
| IS Family Size
|
Non-US Coverage
|
Abstract
Not Available
First Claim
Family
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations
Patent Owner(s)
| Patent Owner | Address |
|---|---|
| NERVIANO MEDICAL SCIENCES SRL | ITITALY MILAN |
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Inventor(s)
| Inventor Name | Address |
|---|---|
| PEVARELLO PAOLO | 20091 BRESSO (MI) |
| TRAQUANDI GABRIELLA | I-20151 MILAN |
| BRASCA MARIA GABRIELLA | I-20014 NERVIANO (MILAN) |
| FANCELLI DANIELE | I-20147 MILAN |
| PANZERI ACHILLE | 23807 MERATE (LC) |
| VIANELLO PAOLA | 20145 MILANO |
| POLUCCI PAOLO | 22070 CASSINA RIZZARDI |
| ROLETTO FULVIA | MILAN |
| VULPETTI ANNA | BRUGHERIO |
| QUARTIERI FRANCESCA | I-28041 ARONA (NO) |
| FERGUSON RON | 21020 CASALE LITTA |
| ALESSIO ROBERTO D | VIA SAN PAOLO 5 I-20092 CINISELLO BALSAMO MILÃO IT |
Cited Art Landscape
- No Cited Art to Display
| DATE PUBLISHED | PUBLICATION/PATENT NO. | PUBLICATION TYPE |
|---|---|---|
| March 15, 2016 |
IS,2939,B
IS2939B
|
PATENT SPECIFICATION |
| November 18, 2005 |
IS,8132,A
IS8132A
|
PATENT APPLICATION MADE AVAILABLE TO THE PUBLIC |
Full Text
Legal Events
Matter Detail
Update Public Data
Dismiss
Edit
Save
Renewals Detail
Edit
Save
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.
